Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Treatment Conundrums: Not Always Black and White

289 - Should I avoid piperacillin, tazobactam and vancomycin for patients at risk for acute kidney injury?

Friday, October 18, 2024
11:20 AM – 11:45 AM US PT
Location: Concourse 151
Disclosure(s):
Kate DeSear, PharmD, BCIDP, AAHIVP, FIDSA: AbbVie Inc: Advisor/Consultant (Terminated, May 10, 2024); Basilea Pharmaceutica: Advisor/Consultant (Terminated, July 1, 2023); GSK: Advisor/Consultant (Terminated, January 8, 2024); La Jolla (Entasis): Advisor/Consultant (Terminated, July 1, 2023); Melinta Therapuetics: Advisor/Consultant (Terminated, June 21, 2023)